107 related articles for article (PubMed ID: 1786895)
1. [Neutrophil function in hematologic disorders].
Matzner Y
Harefuah; 1991 Dec; 121(11):449-52. PubMed ID: 1786895
[No Abstract] [Full Text] [Related]
2. Granulocyte dysfunction in hematological disorders.
Matzner Y
Cancer Invest; 1992; 10(2):155-61. PubMed ID: 1551025
[No Abstract] [Full Text] [Related]
3. Lipoxygenase products in myeloproliferative disorders: increased leukotriene C4 and decreased lipoxin formation in chronic myeloid leukemia.
Stenke L; Näsman-Glaser B; Edenius C; Samuelsson J; Palmblad J; Lindgren JA
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():883-6. PubMed ID: 1825431
[No Abstract] [Full Text] [Related]
4. In vitro thymidine uptake by circulating leukocytes.
Sokal JE; Pauly JL
J Lab Clin Med; 1974 Nov; 84(5):681-91. PubMed ID: 4283790
[No Abstract] [Full Text] [Related]
5. The neutrophil granulocyte in chronic myeloid leukemia.
Carulli G
Haematologia (Budap); 1993; 25(1):35-55. PubMed ID: 8339997
[TBL] [Abstract][Full Text] [Related]
6. Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders.
Cortes J; Giles F; O'Brien S; Thomas D; Albitar M; Rios MB; Talpaz M; Garcia-Manero G; Faderl S; Letvak L; Salvado A; Kantarjian H
Cancer; 2003 Jun; 97(11):2760-6. PubMed ID: 12767088
[TBL] [Abstract][Full Text] [Related]
7. Cellular deformability studies in leukemia.
Sharma K
Physiol Chem Phys Med NMR; 1993; 25(4):293-7. PubMed ID: 8153154
[TBL] [Abstract][Full Text] [Related]
8. Platelet function in acute leukemias.
Naresh KN; Sivasankaran P; Veliath AJ
J Assoc Physicians India; 1993 Jun; 41(6):377-8. PubMed ID: 8005978
[TBL] [Abstract][Full Text] [Related]
9. [Myelocytosis in adults. Diagnostic orientation].
Bernard P
Rev Prat; 1995 Jun; 45(11):1413-6. PubMed ID: 7659993
[No Abstract] [Full Text] [Related]
10. Myeloproliferative disorders. Classification and diagnostic features with special emphasis on chronic myelogenous leukemia and agnogenic myeloid metaplasia.
Hyun BH; Gulati GL; Ashton JK
Clin Lab Med; 1990 Dec; 10(4):825-38. PubMed ID: 2272176
[TBL] [Abstract][Full Text] [Related]
11. [Interferons in the treatment of hematological diseases].
Jantunen E; Nousiainen T
Duodecim; 1998; 114(12):1240-7. PubMed ID: 11524770
[No Abstract] [Full Text] [Related]
12. [Results of selected cytochemical studies of mature granulocytes in myelodysplastic syndromes and various other hematologic diseases].
Mariańska B; Apel D; Maj S
Acta Haematol Pol; 1991; 22(1):54-7. PubMed ID: 1823968
[TBL] [Abstract][Full Text] [Related]
13. Beyond chronic myelogenous leukemia: potential role for imatinib in Philadelphia-negative myeloproliferative disorders.
Cortes J; Kantarjian H
Cancer; 2004 May; 100(10):2064-78. PubMed ID: 15139047
[TBL] [Abstract][Full Text] [Related]
14. [Hematological aspects of acro-syndromes].
Schmidt PM
Rev Med Suisse Romande; 1992 May; 112(5):413-6. PubMed ID: 1604102
[No Abstract] [Full Text] [Related]
15. Induction chemotherapy and post-remission imatinib therapy for de Novo BCR-ABL-positive AML.
Lazarevic V; Golovleva I; Nygren I; Wahlin A
Am J Hematol; 2006 Jun; 81(6):470-1. PubMed ID: 16680752
[No Abstract] [Full Text] [Related]
16. [Molecular biologic study in chronic myelogenous leukemia and its related disorders].
Ohyashiki JH; Ohyashiki K; Toyama K
Rinsho Ketsueki; 1988 Jul; 29(7):1010-7. PubMed ID: 3184468
[No Abstract] [Full Text] [Related]
17. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
[TBL] [Abstract][Full Text] [Related]
18. [Granulocyte dysfunction in hematological diseases].
Matzner Y
Gematol Transfuziol; 1993 May; 38(5):41-4. PubMed ID: 8034174
[No Abstract] [Full Text] [Related]
19. Hematopathologic findings in the myeloproliferative disorders.
Dickstein JI; Vardiman JW
Semin Oncol; 1995 Aug; 22(4):355-73. PubMed ID: 7638633
[TBL] [Abstract][Full Text] [Related]
20. p190 bcr-abl rearrangement: a secondary cytogenetic event in some chronic myeloid disorders?
Roumier C; Daudignon A; Soenen V; Dupriez B; Wetterwald M; Lai JL; Cosson A; Fenaux P; Preudhomme C
Haematologica; 1999 Dec; 84(12):1075-80. PubMed ID: 10586207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
